ERYTHROMYCIN
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
51407-853 -
Package NDC
51407-853-30 -
Application number
ANDA211975 -
SPL ID
27c1ce89-9cfb-b5af-e063-6394a90a151b -
SPL set ID
0c0560be-fb11-509d-e063-6394a90ab6f7 -
UNII
63937KV33D -
RxCUI
310155 -
RxCUI
310157
What the source publishes
- Labeler
- Golden State Medical Supply, Inc.
- Active ingredients
- ERYTHROMYCIN
- Form
- TABLET, DELAYED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "ERYTHROMYCIN",
"splId": "27c1ce89-9cfb-b5af-e063-6394a90a151b",
"labels": [
{
"setId": "0c0560be-fb11-509d-e063-6394a90ab6f7",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c0560be-fb11-509d-e063-6394a90ab6f7",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c0560be-fb11-509d-e063-6394a90ab6f7"
}
],
"routes": [
"ORAL"
],
"labeler": "Golden State Medical Supply, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, DELAYED RELEASE in 1 BOTTLE (51407-853-30)",
"package_ndc": "51407-853-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20231207"
}
],
"productId": "51407-853_27c1ce89-9cfb-b5af-e063-6394a90a151b",
"useDomain": "unknown",
"dosageForm": "TABLET, DELAYED RELEASE",
"productNdc": "51407-853",
"deaSchedule": null,
"genericName": "ERYTHROMYCIN",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ERYTHROMYCIN",
"strength": "250 mg/1"
}
],
"applicationNumber": "ANDA211975",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210726",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000009982",
"N0000175877",
"N0000175935",
"M0028311"
],
"unii": [
"63937KV33D"
],
"rxcui": [
"310155",
"310157"
],
"spl_set_id": [
"0c0560be-fb11-509d-e063-6394a90ab6f7"
],
"pharm_class_cs": [
"Macrolides [CS]"
],
"pharm_class_pe": [
"Decreased Sebaceous Gland Activity [PE]"
],
"pharm_class_epc": [
"Macrolide [EPC]",
"Macrolide Antimicrobial [EPC]"
],
"manufacturer_name": [
"Golden State Medical Supply, Inc."
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:51407-853_27c1ce89-9cfb-b5af-e063-6394a90a151b"